In vitro model for priocidal activity
CA 2964442 C · Owner: Steris Inc. · Inventors: Mcdonnell, Gerald E.; Antloga, Kathleen M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A proteinaceous material has been found to show similar activity and treatment response to that of disease causing prions such as CJD. A prion model which incorporates the proteinaceous material has a variety of applications. The model has an ability to be cultured either in vivo or in vitro allowing rapid screening of potential drugs for treating animals or humans or methods of treating food products or items which may come into contact with prions such as medical or dental devices. Several treatment methods and materials have been developed using the model.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 4, 2002 and granted July 17, 2018. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 4, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 4, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.